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Introduction
Cervical carcinoma is the second most common cause
of cancer-related death in women worldwide. It has
been well established that organized cytologic screening
programs can substantially reduce the incidence of
morbidity and mortality from cervical cancer in devel-
oped countries [1].
Opinions differ regarding the benefits of using a
douche, which is a universally accepted treatment for
vaginitis, to aid health care of the lower genital tract.
The efficacy of douching as a means of eradicating lower
genital tract inflammation has been questioned [2–4].
Limited data exist in the literature concerning the effect
of vaginal douches on human papillomavirus (HPV)
activity. Our study investigated the effect of douching
on the results of HPV tests.
Cervical cancer typically occurs in the fifth and
sixth decades of life, and 27% of patients are aged over
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SUMMARY
Objective: To evaluate whether human papillomavirus (HPV) activity in symptomatic patients with abnormal
Papanicolaou smears (minimal abnormal cytology) was affected by a complete vaginal douche, applied to the
cervix prior to colposcopic examination.
Materials and Methods: A total of 132 women with abnormal Papanicolaou smears were prospectively regis-
tered in this study from 1999 to 2004. Two specimens were collected from each patient; one before and one
after the cervix was swabbed with a complete vaginal douche during a colposcopic examination. We compared
the HPV detection results before and after douching in the same patients. The samples were analyzed using the
Hybrid Capture II assay.
Results: Before douching, 57.6% (76/132) of the samples were HPV-positive, compared with 58.3% (77/132)
of the samples after douching. There was a strong correlation between the cervical HPV detection rates between
the before and after douche samples (p < 0.001). The kappa statistic was 0.891 for the correlation (positive–
positive, negative–negative) and the discrepancy (positive–negative) between the inter-douche rates of HPV
activity. A comparison of the HPV assay before and after vaginal douching demonstrated a statistically signifi-
cant relationship (p < 0.001). The sensitivity of the HPV test after douching was higher (97.8%) than that before
douching (95.6%). The false-negative rate before douching in women with inflammatory smears was 3% (4/132)
and the false-positive rate before douching in women with atypical squamous cells of undetermined significance
was 2.1% (3/132).
Conclusion: Our results indicate that self-administration of a vaginal douche is not a reliable method of eradicating
HPV infection. [Taiwan J Obstet Gynecol 2008;47(4):412–416]
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65 [5,6]. Delivering preventive care in primary care
practices is often more difficult in rural areas than in
urban areas. Medical practice also differs in rural areas,
where there are fewer physicians and less contact with
physicians [7]. Important limitations exist regarding
the screening of samples obtained during pelvic exami-
nation, such as the fact that such examinations require
a trained health professional working in a clinical set-
ting. In addition, cultural inhibitions often render rou-
tine pelvic examinations unacceptable to symptomatic
women from certain ethnic backgrounds. These factors
limit the utilization of the screening services [8].
Epidemiologic and basic molecular biology studies
support the concept that certain genital HPV strains
are major risk factors for the development of cervical
cancer and are responsible for 85–95% of human cer-
vical carcinomas. HPV typing is important in order to
identify women at risk of cervical cancer [9,10]. The
clinical usefulness of HPV testing using the Hybrid
Capture II (HC II) system has been evaluated in a num-
ber of studies, and it has been shown that this test can
be used for the early detection of cervical precancer or
cancer [11–15].
The aim of this study was to identify whether or not
vaginal douching helped to eradicate HPV infection in
women with mildly abnormal Papanicolaou (Pap) cytol-
ogy. Possible effects on the sensitivity of HPV testing
were also evaluated.
Materials and Methods
Participants who had mildly abnormal cytologic results
for Pap smears using the Bethesda system were referred
to the colposcopic clinic at Chang Gung Memorial
Hospital, and were then recruited to this study. A total
of 132 patients were enrolled from September 1999 to
September 2004.
Following signed informed consent, a careful
inspection of the external genitalia and perianal area
was performed to detect any evidence of HPV-related
diseases. A vaginal speculum was then inserted and a
sterile conical brush was used to collect cells for HPV
DNA analysis. This applicator was a part of a com-
mercial kit, i.e. the Digene Hybrid Capture II System
(Digene Inc., Silver Spring, MD, USA) [14]. Cells were
collected from the endocervix and the transformation
zone and added to 1.0 mL of specimen transport
medium. A colposcopic examination was then carried
out with 5% acetic acid, according to the standard
protocol. After douching with the acetic acid, a second
HPV brush was inserted for cell collection. The entire
transformation zone was observed for any lesions and
the colposcopic findings were recorded. If a lesion was
seen, a punch biopsy specimen was taken from the most
significant area.
Specimens were processed for HPV testing according
to the manufacturer’s instructions. The Digene Hybrid
Capture II System is a sandwich capture molecular
hybridization assay that employs chemiluminescence
detection. The specimens were treated with alkaline
denaturation solution at 65°C for 45 minutes and
hybridized under high stringency with a mixture of spe-
cific RNA probes for HPV types 16, 18, 31, 33, 35, 39,
45, 51, 52, 56, 58, 59 and 68. The resultant DNA–
RNA hybrids were captured on the surface of the
microtiter plate wells coated with an anti-DNA–RNA
hybrid antibody. The immobilized hybrids reacted with
the alkaline phosphatase-conjugated anti-hybrid mono-
clonal antibody. Light was emitted and measured as
relative light units (RLUs) using a luminometer. The
intensity of the light emitted was proportional to the
amount of target DNA in the specimen. An RLU mea-
surement greater than or equal to the positive control
cutoff value (0.2 pg/mL HPV DNA) indicated the pres-
ence of HPV sequences in the patient’s specimen,
whereas an RLU measurement less than the cutoff
value indicated the absence of HPV sequences.
The sensitivity, specificity, positive predictive value
and negative predictive value were calculated using the
final histologic diagnoses as the standard. Reliability
was assessed by pairwise inter-douche vaginal HPV test
comparisons using the kappa statistic. As a general
guide, a kappa value > 0.75 represents excellent agree-
ment beyond that expected by chance, values < 0.40
represent poorer agreement than that expected by
chance, and values between 0.40 and 0.75 suggest fair
to good agreement relative to that expected by chance.
The association between HPV infection detection before
and after vaginal douching was examined using the
Chi-squared or Fisher’s exact test. A p value of < 0.05
was considered statistically significant.
Results
The study group included 132 women who had minimal
abnormal cytology on routine cytologic cervical exami-
nation. They, therefore, underwent colposcopic exam-
ination and/or directed biopsy with douche. All gave
their informed consent to their participation in this
study. The minimally abnormal smears included 27
cases of low-grade squamous intraepithelial lesions
(LSIL); 52 cases of ASCUS (atypical squamous cells of
undetermined significance) lesions; and 53 cases of
inflammatory smears. HPV was found to be positive in
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19 (70%) of the 27 LSIL smears, 38 (73%) of the 52
ASCUS, and 19 (35.8%) of the 53 apparently inflam-
matory smears.
Before vaginal douching, 76 of 132 (57.6%) sub-
jects exhibited cancer-associated HPV activity. After
douching, HPV infection was detected in 77 of the 132
(58.3%) subjects. In 94.7% of the samples (125/132),
the HPV activity results were the same before and after
vaginal douching (negative remained negative, and pos-
itive remained positive). Douching resulted in a mini-
mal discrepancy rate of 5.3% (7/132), due to a shift in
the vaginal douche population for high-risk HPV activ-
ity. This included tests where a negative result had
turned positive (4/132) in the ASCUS group, or a pos-
itive result had turned negative (3/132) in the inflam-
matory group. Thus the detection of HPV activity was
not influenced by a 5% acetic acid douche in 125 of
the 132 (94.7%) swab samples studied (p < 0.001)
(Tables 1 and 2). The HPV values in the seven swab
samples that changed were very close to the upper
limit of the negative control for the laboratory HC II
test. The vaginal douche completely cleansed the area
of cervical mucinous fluid, thus making the sampling
of cervical cells easier and possibly increasing the HPV
viral load of the samples (data not shown) (Tables 1
and 2). In this series of experiments, the use of self-
administered vaginal cleansing with 5% acetic acid did
not eradicate oncogenic HPV activity.
The inter-douche vaginal reliability of the HC assay
is shown in Table 3. The inter-douche agreement was
generally higher for the positive group (84.2–100%)
than for the negative group (71.4–100%). The positive
group (positive–positive) agreements were 16/19
(84.2%), 38/42 (90.5%) and 19/19 (100%), and the
negative (negative–negative) agreements were 34/37
(91.9%), 10/14 (71.4%) and 8/8 (100%) in the Pap
smears, indicating infection, ASCUS or LSIL, respec-
tively. The kappa statistic was 0.891 for correlation
(positive–positive, negative–negative) and discrepancy
(positive–negative) of HPV activity, comparing vaginal
douching as a whole. Comparison of the before and
after vaginal douche HPV activities demonstrated sta-
tistical significance (χ2 = 104.863, p < 0.001).
Discussion
Cancer-associated HPV infection and the effects of
vaginal douching are an issue for many women. How-
ever, there is a lack of adequate medical literature about
self-administered vaginal douches and HPV infection.
In our experience, Taiwanese women usually perform
vaginal cleansing at home, despite symptomatic vaginal
Table 3. Pairwise agreement before and after vaginal 
douche for human papillomavirus (HPV) detection*
Pap result
HPV testing Agreement Agreement 
on positivity on negativity
Inflammation 16/19 (84.2%) 34/37 (91.9%)
ASCUS 38/42 (90.5%) 10/14 (71.4%)
LSIL 19/19 (100%) 8/8 (100%)
*k statistic = 0.89, χ2 = 104.863, p < 0.001. ASCUS = atypical squamous cell
of undetermined significance; LSIL = low-grade squamous intraepithelial lesion.
Table 2. Comparison of rate of change in human papillomavirus (HPV) detection before and after vaginal douching
Pap results
HPV testing
−/− −/+ +/− +/+
χ2 κ p
Inflammation 34/37 0/0 3/3 19/16 41.013 0.872 < 0.001
ASCUS 14/10 4/4 0/0 38/42 33.605 0.785 < 0.001
LSIL 8/8 0/0 0/0 19/19 27.00 1.000 < 0.001
ASCUS = atypical squamous cell of undetermined significance; LSIL = low-grade squamous intraepithelial lesion.
Table 1. Detection of human papillomavirus (HPV) before and after vaginal douching
Before douche After douche
HPV testing n
Positive Pap result Negative Pap result Positive Pap result Negative Pap result
Inflammation 53 19 34 16 37
ASCUS 52 38 14 42 10
LSIL 27 19 8 19 8
Total 132 76 56 77 55
ASCUS = atypical squamous cell of undetermined significance; LSIL = low-grade squamous intraepithelial lesion.
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bleeding and regardless of education. In the United
States, 90% of women still perform self-bathing for
lower genital tract infections [2]. Our use of a simple
and safe test for detecting oncogenic HPV sheds light
on the effect of vaginal douching on HPV infection/
detection.
Our hospital in Taiwan has been using the HC II
method to detect high-risk HPV, in addition to the
minimal abnormal Pap smear method, for many years.
The question of whether or not vaginal douching, self-
bathing of the lower genital tract, or use of vaginal drugs
can cause the HPV test to give false results has been
posed previously, and we have attempted to answer this
important question in this prospective study. Long-term
infection with oncogenic HPV types seems to be one of
the underlying factors responsible for the development
of cervical cancer [4–6]. In our experience, the HC II assay
has excellent sensitivity and has a good negative pre-
dictive value for the detection of cervical intraepithelial
neoplasia or cancer. Overall, the sensitivity of the HC II
assay in detecting high-grade lesions is 100%, versus
85.9% for standard cytology. However, its specificity
(86.3%) and positive predictive value are not as high as
the latter [16–19]. Thus, the HC II test is suitable for
confirming negative results for cervical carcinoma
[17–20].
A complete vaginal douche might be expected to
reduce any cancer-associated HPV activity, because 5%
acetic acid is able to cleanse the mucinous cervical
transformation region and HPV-infected cervical lesions,
so possibly causing the HC II test to yield false negative
results. On the other hand, the douche may lead to
improved sampling of infected cervical cells compared
with reduced sampling of uninfected uterine cells. Age
could also potentially affect the reliability of the test
results. Older women (> 50 years old) have a drier lower
genital tract due to menopause, as well as anatomic
narrowing of the cervix opening, which may retain
infected cells higher in the cervical canal and result in
poorer viral sampling [19]. A vaginal douche with 5%
acetic acid for 1 minute covering the cervical orifice
induces relaxation of the cervical canal, which may allow
sampling from lesions higher in the canal and thus lead
to better detection.
In conclusion, douching does not eliminate the pres-
ence of oncogenic HPV in lower genital tract inflamma-
tion. Advances in the diagnosis of cervical cancer have
resulted in an overall reduction in the number of deaths
from cervical cancer. However, there is still a need for
further education regarding cervical cancer and its risk
factors. This study provides information that may be
of use epidemiologically and for the future prevention
and/or treatment of cervical cancer.
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